Inhibition by calcium antagonist of coupling of insulin binding and insulin action on glucose transport in isolated fat cells.

F. Ishibashi,K. Kubo

1984-03-01

Abstract:In the present study we examined the influence of calcium antagonist, nicardipineHCl, on insulin binding and insulin action on glucose transport in isolated fat cells. The calcium antagonist did not influence the time course of 125I-insulin binding or the insulin concentration required for 50% displacement of 125I-insulin binding. Calcium antagonist prolonged the lag time of insulin action on glucose transport. Calcium antagonist, however, did not influence the insulin concentration required for half maximal response. The prolongation of the lag time was also seen with 2 different calcium antagonists (verapamil and diltiazem-HCl). Calcium antagonists might impair the transmission of signal from insulin receptor by other mechanism(s) rather than the inhibition of transmembrane transport of calcium, because calcium antagonist did not inhibit 45Ca uptake and efflux from preloaded fat cells, and because known calmodulin inhibitors (trifluoperazine and prochlorperazine) prolonged the lag time for insulin action without influence on insulin concentration for the half maximal response. In conclusion calcium antagonist might act to calmodulin, phospholipids or membrane proteins. 73 INTRODUCTION suiting in decreased cytosolic Ca2 + concentration. Several drugs with similar pharmacological effects, despite the difference in chemical structure are thought specifically to block Ca2+ influx, and grouped together as calcium antagonists7>. They inhibit contraction of heart and smooth muscle9>, and the release of pancreatic hormones11 • 13>. Intracellular free calcium has been considered as a possible mediator of insulin action 6>. In isolated rat adipocytes insulin increases influx of Ca2+ 5> or decreases Ca + efflux10> resulting in increased cytosolic Ca2+ concentration. Otherwise, insulin increases Ca2+ binding to plasma membrane14> and endoplasmic reticulum3>, reRecently it became evident that calcium antagonist inhibits the contraction of smooth muscle of vessel, or of heart without influence on calcium influx2• 4> and might act directly on calcium binding proteins such as calmodulin2>. We studied the effects of newly developed calcium antagonist, nicardipine-HCI, on insulin binding and action on 3-0-methylglucose transport in rat isolated fat cells, and discussed the action mechanism(s) of calcium antagonist on insulin action. MATERIALS AND METHODS